AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-K$APT

ALPHA PRO TECH, LTD. ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

ALPHA PRO TECH LTD (APT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ALPHA PRO TECH, LTD. ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS Third Quarter Net Sales Increased by 12.3% to $16.6 Million, from $14.8 Million for the Third Quarter of 2025 Third Quarter Net Income Increased by 97.2% to $1.9 Million from $1.0 Million in the Prio

Original reporting
SEC EDGAR 8-K
Published Nov 10, 2026, 2:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 2:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$APT
Bullish
high confidence
Mentioned
$APT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$APTBullishMed
01

Why it matters

The earnings beat and strong cash position suggest short‑term upside, but tariff exposure and a soft housing outlook temper the rally.

02

Market read

Micro‑cap earnings with notable profit growth; may attract momentum traders but limited broader market effect.

03

What to watch

The 10% tariff under Section 122 could erode profit gains; cash burn risk if sales slowdown resumes.

Relevance 7/10Novelty 7/10Timing: post‑market release

Background

Alpha Pro Tech (NYSE American: APT) is a manufacturer of disposable protective apparel and building‑supply products. The filing is its first quarterly earnings release for Q3 2026.

Company-level read

Ticker impact

$APTBullishHigh confidence
Context

Alpha Pro Tech reported Q3 2026 net sales up 12.3% to $16.6M and net income up 97% to $1.9M in its SEC 8‑K filing.

Expected impact

likely modest upside as market prices in higher earnings and cash position

Evidence & confidence

The company posted double‑digit profit growth, no debt, and raised cash, which should support a short‑term price lift.

Market effects

Sector

Positive earnings may boost sentiment in the building‑supply and protective‑apparel niche.

Regional

Limited to U.S. small‑cap investors; no broader regional effect.

Global

Minimal global impact; primarily a micro‑cap earnings update.

Counterpoint

What could challenge this read

Growth may be unsustainable if housing market weakness persists; margins could compress under new tariffs.

Key entities

  • company
    Alpha Pro Tech, Ltd.

    Issuer of the earnings release.

  • executive
    Lloyd Hoffman

    President and CEO who commented on the results.

Read at source← All news

Related articles

$APTMed

ALPHA PRO TECH, LTD. ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS

ALPHA PRO TECH LTD (APT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ALPHA PRO TECH, LTD. ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Second Quarter Net Sales Increased by 12% to $18.7 Million from $16.7 Million in the Second Quarter of 2025; Second Quarter Net Income Increased by 47% to $1.8 Million from $1.2 Million in the Prior

SEC EDGAR 8-K
$CPIXMedAI 8/10

Cumberland Pharmaceuticals Q3 Earnings Call Highlights

Cumberland Pharmaceuticals (CPIX) reported Q3 earnings, including a $108M net funding estimate from a transaction, a $1.50 special dividend, and share repurchase plans. The company projects cash to fund operations for over five years. Cumberland is preparing a new drug application for ifetroban to treat Duchenne muscular dystrophy, with FDA rolling review granted. The company also discussed other clinical programs and retained majority ownership of Cumberland Emerging Technologies.

finance.yahoo.com
$GOHighAI 8/10

What Grocery Outlet (GO) Said on Its Q3 Earnings Call

Grocery Outlet (GO) reported Q3 adjusted earnings of $0.16 per share, down from $0.21 a year earlier, with adjusted EBITDA falling to $59.4 million. The company cited promotional spending, higher supply chain costs, and increased produce shrink for the decline. GO forecasted Q4 comparable-store sales growth of 1.5% to 2.5% and adjusted earnings of $0.11 to $0.14 per share. The company plans to open 20-31 net new stores in 2027, all in existing markets.

finance.yahoo.com
$CAPRLow

Capricor Therapeutics Q3 Earnings Call Highlights

Capricor Therapeutics reported a Q3 net loss of $42.7M, widening from $24.6M a year earlier. The company highlighted positive data on Deramiocel, its lead therapy, showing improved upper limb function in patients. Capricor is preparing for a potential launch while resolving a distribution dispute with Nippon Shinyaku. The company has sufficient cash to fund operations for at least 12 months.

finance.yahoo.com